Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07271069

Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis

Real-world Effectiveness of Ozanimod in Patients With Steroid-Dependent Ulcerative Colitis: A Chart Review Study

Status
Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Bristol-Myers Squibb · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the effectiveness and safety of ozanimod vs azathioprine for the treatment of ulcerative colitis (UC) in real-world clinical practice in Japan

Conditions

Interventions

TypeNameDescription
DRUGOzanimodAccording to the product label
DRUGAzathioprineAccording to the product label

Timeline

Start date
2026-01-29
Primary completion
2027-03-31
Completion
2027-12-31
First posted
2025-12-08
Last updated
2026-04-13

Locations

17 sites across 1 country: Japan

Regulatory

Source: ClinicalTrials.gov record NCT07271069. Inclusion in this directory is not an endorsement.